http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 30 Aug 2024 21:43:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Management+Changes/23674999.html <p align="justify">TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (OTC: MEDVF; FRA: 4NC) announces today that David Preiner has resigned from his position as president and chief executive officer of the Company, effective August 26, 2024. Mr. Preiner will continue to support the Company in his capacity as a consultant. The board and management thanks Preiner for his service and contributions and wish him well in his future endeavours.<br/></p> <p align="justify"><strong>About Medivolve</strong></p> <p align="justify"><a target="_blank" href="https://www.globenewswire.com/Tracker?data=hVl1WiQ2JGQ_lf4xNT-T01vwo_9UsgWI8FrPxP7wfUofpzntXPsIUx16uM0L8xcZpQmsvP63HEJzn50JMAbuGg==" rel="nofollow" target="_blank">Medivolve</a> is a Canadian healthcare technology company headquartered in Toronto, Canada. http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Management+Changes/23674999.html Fri, 30 Aug 2024 21:43:00 -0400 4NCA.F MEDV MEDV.NE MEDVF O.05948651 http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Management+Changes/23674999.html <p align="justify">TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (OTC: MEDVF; FRA: 4NC) announces today that David Preiner has resigned from his position as president and chief executive officer of the Company, effective August 26, 2024. Mr. Preiner will continue to support the Company in his capacity as a consultant. The board and management thanks Preiner for his service and contributions and wish him well in his future endeavours.<br/></p> <p align="justify"><strong>About Medivolve</strong></p> <p align="justify"><a target="_blank" href="https://www.globenewswire.com/Tracker?data=hVl1WiQ2JGQ_lf4xNT-T01vwo_9UsgWI8FrPxP7wfUofpzntXPsIUx16uM0L8xcZpQmsvP63HEJzn50JMAbuGg==" rel="nofollow" target="_blank">Medivolve</a> is a Canadian healthcare technology company headquartered in Toronto, Canada. http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Management+Changes/23674999.html Fri, 30 Aug 2024 21:43:00 -0400 4NCA.F MEDV MEDV.NE MEDVF O.05948651 http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Management+Changes/23674999.html <p align="justify">TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (OTC: MEDVF; FRA: 4NC) announces today that David Preiner has resigned from his position as president and chief executive officer of the Company, effective August 26, 2024. Mr. Preiner will continue to support the Company in his capacity as a consultant. The board and management thanks Preiner for his service and contributions and wish him well in his future endeavours.<br/></p> <p align="justify"><strong>About Medivolve</strong></p> <p align="justify"><a target="_blank" href="https://www.globenewswire.com/Tracker?data=hVl1WiQ2JGQ_lf4xNT-T01vwo_9UsgWI8FrPxP7wfUofpzntXPsIUx16uM0L8xcZpQmsvP63HEJzn50JMAbuGg==" rel="nofollow" target="_blank">Medivolve</a> is a Canadian healthcare technology company headquartered in Toronto, Canada. http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Management+Changes/23674999.html Fri, 30 Aug 2024 21:43:00 -0400 4NCA.F MEDV MEDV.NE MEDVF O.05948651 http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Management+Changes/23674999.html <p align="justify">TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (OTC: MEDVF; FRA: 4NC) announces today that David Preiner has resigned from his position as president and chief executive officer of the Company, effective August 26, 2024. Mr. Preiner will continue to support the Company in his capacity as a consultant. The board and management thanks Preiner for his service and contributions and wish him well in his future endeavours.<br/></p> <p align="justify"><strong>About Medivolve</strong></p> <p align="justify"><a target="_blank" href="https://www.globenewswire.com/Tracker?data=hVl1WiQ2JGQ_lf4xNT-T01vwo_9UsgWI8FrPxP7wfUofpzntXPsIUx16uM0L8xcZpQmsvP63HEJzn50JMAbuGg==" rel="nofollow" target="_blank">Medivolve</a> is a Canadian healthcare technology company headquartered in Toronto, Canada. http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Management+Changes/23674999.html Fri, 30 Aug 2024 21:43:00 -0400 4NCA.F MEDV MEDV.NE MEDVF O.05948651 http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Management+Changes/23674999.html <p align="justify">TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (OTC: MEDVF; FRA: 4NC) announces today that David Preiner has resigned from his position as president and chief executive officer of the Company, effective August 26, 2024. Mr. Preiner will continue to support the Company in his capacity as a consultant. The board and management thanks Preiner for his service and contributions and wish him well in his future endeavours.<br/></p> <p align="justify"><strong>About Medivolve</strong></p> <p align="justify"><a target="_blank" href="https://www.globenewswire.com/Tracker?data=hVl1WiQ2JGQ_lf4xNT-T01vwo_9UsgWI8FrPxP7wfUofpzntXPsIUx16uM0L8xcZpQmsvP63HEJzn50JMAbuGg==" rel="nofollow" target="_blank">Medivolve</a> is a Canadian healthcare technology company headquartered in Toronto, Canada. http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Management+Changes/23674999.html Fri, 30 Aug 2024 21:43:00 -0400 4NCA.F MEDV MEDV.NE MEDVF O.05948651 http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Management+Changes/23674999.html <p align="justify">TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (OTC: MEDVF; FRA: 4NC) announces today that David Preiner has resigned from his position as president and chief executive officer of the Company, effective August 26, 2024. Mr. Preiner will continue to support the Company in his capacity as a consultant. The board and management thanks Preiner for his service and contributions and wish him well in his future endeavours.<br/></p> <p align="justify"><strong>About Medivolve</strong></p> <p align="justify"><a target="_blank" href="https://www.globenewswire.com/Tracker?data=hVl1WiQ2JGQ_lf4xNT-T01vwo_9UsgWI8FrPxP7wfUofpzntXPsIUx16uM0L8xcZpQmsvP63HEJzn50JMAbuGg==" rel="nofollow" target="_blank">Medivolve</a> is a Canadian healthcare technology company headquartered in Toronto, Canada. http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Management+Changes/23674999.html Fri, 30 Aug 2024 21:43:00 -0400 4NCA.F MEDV MEDV.NE MEDVF O.05948651 http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Management+Changes/23674999.html <p align="justify">TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (OTC: MEDVF; FRA: 4NC) announces today that David Preiner has resigned from his position as president and chief executive officer of the Company, effective August 26, 2024. Mr. Preiner will continue to support the Company in his capacity as a consultant. The board and management thanks Preiner for his service and contributions and wish him well in his future endeavours.<br/></p> <p align="justify"><strong>About Medivolve</strong></p> <p align="justify"><a target="_blank" href="https://www.globenewswire.com/Tracker?data=hVl1WiQ2JGQ_lf4xNT-T01vwo_9UsgWI8FrPxP7wfUofpzntXPsIUx16uM0L8xcZpQmsvP63HEJzn50JMAbuGg==" rel="nofollow" target="_blank">Medivolve</a> is a Canadian healthcare technology company headquartered in Toronto, Canada. http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Management+Changes/23674999.html Fri, 30 Aug 2024 21:43:00 -0400 4NCA.F MEDV MEDV.NE MEDVF O.05948651 http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Management+Changes/23674999.html <p align="justify">TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (OTC: MEDVF; FRA: 4NC) announces today that David Preiner has resigned from his position as president and chief executive officer of the Company, effective August 26, 2024. Mr. Preiner will continue to support the Company in his capacity as a consultant. The board and management thanks Preiner for his service and contributions and wish him well in his future endeavours.<br/></p> <p align="justify"><strong>About Medivolve</strong></p> <p align="justify"><a target="_blank" href="https://www.globenewswire.com/Tracker?data=hVl1WiQ2JGQ_lf4xNT-T01vwo_9UsgWI8FrPxP7wfUofpzntXPsIUx16uM0L8xcZpQmsvP63HEJzn50JMAbuGg==" rel="nofollow" target="_blank">Medivolve</a> is a Canadian healthcare technology company headquartered in Toronto, Canada. http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Management+Changes/23674999.html Fri, 30 Aug 2024 21:43:00 -0400 4NCA.F MEDV MEDV.NE MEDVF O.05948651 http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Management+Changes/23674999.html <p align="justify">TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (OTC: MEDVF; FRA: 4NC) announces today that David Preiner has resigned from his position as president and chief executive officer of the Company, effective August 26, 2024. Mr. Preiner will continue to support the Company in his capacity as a consultant. The board and management thanks Preiner for his service and contributions and wish him well in his future endeavours.<br/></p> <p align="justify"><strong>About Medivolve</strong></p> <p align="justify"><a target="_blank" href="https://www.globenewswire.com/Tracker?data=hVl1WiQ2JGQ_lf4xNT-T01vwo_9UsgWI8FrPxP7wfUofpzntXPsIUx16uM0L8xcZpQmsvP63HEJzn50JMAbuGg==" rel="nofollow" target="_blank">Medivolve</a> is a Canadian healthcare technology company headquartered in Toronto, Canada. http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Management+Changes/23674999.html Fri, 30 Aug 2024 21:43:00 -0400 4NCA.F MEDV MEDV.NE MEDVF O.05948651 http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Management+Changes/23674999.html <p align="justify">TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (OTC: MEDVF; FRA: 4NC) announces today that David Preiner has resigned from his position as president and chief executive officer of the Company, effective August 26, 2024. Mr. Preiner will continue to support the Company in his capacity as a consultant. The board and management thanks Preiner for his service and contributions and wish him well in his future endeavours.<br/></p> <p align="justify"><strong>About Medivolve</strong></p> <p align="justify"><a target="_blank" href="https://www.globenewswire.com/Tracker?data=hVl1WiQ2JGQ_lf4xNT-T01vwo_9UsgWI8FrPxP7wfUofpzntXPsIUx16uM0L8xcZpQmsvP63HEJzn50JMAbuGg==" rel="nofollow" target="_blank">Medivolve</a> is a Canadian healthcare technology company headquartered in Toronto, Canada. http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Management+Changes/23674999.html Fri, 30 Aug 2024 21:43:00 -0400 4NCA.F MEDV MEDV.NE MEDVF O.05948651 http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Change+of+Auditor/22759470.html <p align="justify">TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from MNP LLP (“MNP”) to MS Partners LLP (“MS Partners”), effective February 6, 2024. MNP resigned as of the effective date of January 16, 2024, and MS Partners has been appointed as the successor auditor. In accordance with National Instrument 51‐102 (“NI 51‐102”), the Company has filed a Change of Auditor Notice on SEDAR+ together with letters from both MNP and MS Partners, with each letter confirming agreement with the statements contained http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Change+of+Auditor/22759470.html Mon, 12 Feb 2024 18:00:00 -0400 4NCA A.30400265 MEDV MEDVD MEDVF O.05948651 O.49066140 http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Change+of+Auditor/22759470.html <p align="justify">TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from MNP LLP (“MNP”) to MS Partners LLP (“MS Partners”), effective February 6, 2024. MNP resigned as of the effective date of January 16, 2024, and MS Partners has been appointed as the successor auditor. In accordance with National Instrument 51‐102 (“NI 51‐102”), the Company has filed a Change of Auditor Notice on SEDAR+ together with letters from both MNP and MS Partners, with each letter confirming agreement with the statements contained http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Change+of+Auditor/22759470.html Mon, 12 Feb 2024 18:00:00 -0400 4NCA A.30400265 MEDV MEDVD MEDVF O.05948651 O.49066140 http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Change+of+Auditor/22759470.html <p align="justify">TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from MNP LLP (“MNP”) to MS Partners LLP (“MS Partners”), effective February 6, 2024. MNP resigned as of the effective date of January 16, 2024, and MS Partners has been appointed as the successor auditor. In accordance with National Instrument 51‐102 (“NI 51‐102”), the Company has filed a Change of Auditor Notice on SEDAR+ together with letters from both MNP and MS Partners, with each letter confirming agreement with the statements contained http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Change+of+Auditor/22759470.html Mon, 12 Feb 2024 18:00:00 -0400 4NCA A.30400265 MEDV MEDVD MEDVF O.05948651 O.49066140 http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Change+of+Auditor/22759470.html <p align="justify">TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from MNP LLP (“MNP”) to MS Partners LLP (“MS Partners”), effective February 6, 2024. MNP resigned as of the effective date of January 16, 2024, and MS Partners has been appointed as the successor auditor. In accordance with National Instrument 51‐102 (“NI 51‐102”), the Company has filed a Change of Auditor Notice on SEDAR+ together with letters from both MNP and MS Partners, with each letter confirming agreement with the statements contained http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Change+of+Auditor/22759470.html Mon, 12 Feb 2024 18:00:00 -0400 4NCA A.30400265 MEDV MEDVD MEDVF O.05948651 O.49066140 http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Change+of+Auditor/22759470.html <p align="justify">TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from MNP LLP (“MNP”) to MS Partners LLP (“MS Partners”), effective February 6, 2024. MNP resigned as of the effective date of January 16, 2024, and MS Partners has been appointed as the successor auditor. In accordance with National Instrument 51‐102 (“NI 51‐102”), the Company has filed a Change of Auditor Notice on SEDAR+ together with letters from both MNP and MS Partners, with each letter confirming agreement with the statements contained http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Change+of+Auditor/22759470.html Mon, 12 Feb 2024 18:00:00 -0400 4NCA A.30400265 MEDV MEDVD MEDVF O.05948651 O.49066140 http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Change+of+Auditor/22759470.html <p align="justify">TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from MNP LLP (“MNP”) to MS Partners LLP (“MS Partners”), effective February 6, 2024. MNP resigned as of the effective date of January 16, 2024, and MS Partners has been appointed as the successor auditor. In accordance with National Instrument 51‐102 (“NI 51‐102”), the Company has filed a Change of Auditor Notice on SEDAR+ together with letters from both MNP and MS Partners, with each letter confirming agreement with the statements contained http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Change+of+Auditor/22759470.html Mon, 12 Feb 2024 18:00:00 -0400 4NCA A.30400265 MEDV MEDVD MEDVF O.05948651 O.49066140 http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Change+of+Auditor/22759470.html <p align="justify">TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from MNP LLP (“MNP”) to MS Partners LLP (“MS Partners”), effective February 6, 2024. MNP resigned as of the effective date of January 16, 2024, and MS Partners has been appointed as the successor auditor. In accordance with National Instrument 51‐102 (“NI 51‐102”), the Company has filed a Change of Auditor Notice on SEDAR+ together with letters from both MNP and MS Partners, with each letter confirming agreement with the statements contained http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Change+of+Auditor/22759470.html Mon, 12 Feb 2024 18:00:00 -0400 4NCA A.30400265 MEDV MEDVD MEDVF O.05948651 O.49066140 http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Change+of+Auditor/22759470.html <p align="justify">TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from MNP LLP (“MNP”) to MS Partners LLP (“MS Partners”), effective February 6, 2024. MNP resigned as of the effective date of January 16, 2024, and MS Partners has been appointed as the successor auditor. In accordance with National Instrument 51‐102 (“NI 51‐102”), the Company has filed a Change of Auditor Notice on SEDAR+ together with letters from both MNP and MS Partners, with each letter confirming agreement with the statements contained http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Change+of+Auditor/22759470.html Mon, 12 Feb 2024 18:00:00 -0400 4NCA A.30400265 MEDV MEDVD MEDVF O.05948651 O.49066140 http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Change+of+Auditor/22759470.html <p align="justify">TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from MNP LLP (“MNP”) to MS Partners LLP (“MS Partners”), effective February 6, 2024. MNP resigned as of the effective date of January 16, 2024, and MS Partners has been appointed as the successor auditor. In accordance with National Instrument 51‐102 (“NI 51‐102”), the Company has filed a Change of Auditor Notice on SEDAR+ together with letters from both MNP and MS Partners, with each letter confirming agreement with the statements contained http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Change+of+Auditor/22759470.html Mon, 12 Feb 2024 18:00:00 -0400 4NCA A.30400265 MEDV MEDVD MEDVF O.05948651 O.49066140 http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Change+of+Auditor/22759470.html <p align="justify">TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from MNP LLP (“MNP”) to MS Partners LLP (“MS Partners”), effective February 6, 2024. MNP resigned as of the effective date of January 16, 2024, and MS Partners has been appointed as the successor auditor. In accordance with National Instrument 51‐102 (“NI 51‐102”), the Company has filed a Change of Auditor Notice on SEDAR+ together with letters from both MNP and MS Partners, with each letter confirming agreement with the statements contained http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Change+of+Auditor/22759470.html Mon, 12 Feb 2024 18:00:00 -0400 4NCA A.30400265 MEDV MEDVD MEDVF O.05948651 O.49066140 http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Change+of+Auditor/22759470.html <p align="justify">TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from MNP LLP (“MNP”) to MS Partners LLP (“MS Partners”), effective February 6, 2024. MNP resigned as of the effective date of January 16, 2024, and MS Partners has been appointed as the successor auditor. In accordance with National Instrument 51‐102 (“NI 51‐102”), the Company has filed a Change of Auditor Notice on SEDAR+ together with letters from both MNP and MS Partners, with each letter confirming agreement with the statements contained http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Change+of+Auditor/22759470.html Mon, 12 Feb 2024 18:00:00 -0400 4NCA A.30400265 MEDV MEDVD MEDVF O.05948651 O.49066140 http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Change+of+Auditor/22759470.html <p align="justify">TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from MNP LLP (“MNP”) to MS Partners LLP (“MS Partners”), effective February 6, 2024. MNP resigned as of the effective date of January 16, 2024, and MS Partners has been appointed as the successor auditor. In accordance with National Instrument 51‐102 (“NI 51‐102”), the Company has filed a Change of Auditor Notice on SEDAR+ together with letters from both MNP and MS Partners, with each letter confirming agreement with the statements contained http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Change+of+Auditor/22759470.html Mon, 12 Feb 2024 18:00:00 -0400 4NCA A.30400265 MEDV MEDVD MEDVF O.05948651 O.49066140 http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Change+of+Auditor/22759470.html <p align="justify">TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from MNP LLP (“MNP”) to MS Partners LLP (“MS Partners”), effective February 6, 2024. MNP resigned as of the effective date of January 16, 2024, and MS Partners has been appointed as the successor auditor. In accordance with National Instrument 51‐102 (“NI 51‐102”), the Company has filed a Change of Auditor Notice on SEDAR+ together with letters from both MNP and MS Partners, with each letter confirming agreement with the statements contained http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Change+of+Auditor/22759470.html Mon, 12 Feb 2024 18:00:00 -0400 4NCA A.30400265 MEDV MEDVD MEDVF O.05948651 O.49066140 http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Change+of+Auditor/22759470.html <p align="justify">TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from MNP LLP (“MNP”) to MS Partners LLP (“MS Partners”), effective February 6, 2024. MNP resigned as of the effective date of January 16, 2024, and MS Partners has been appointed as the successor auditor. In accordance with National Instrument 51‐102 (“NI 51‐102”), the Company has filed a Change of Auditor Notice on SEDAR+ together with letters from both MNP and MS Partners, with each letter confirming agreement with the statements contained http://www.streetinsider.com/Globe+Newswire/Medivolve+Announces+Change+of+Auditor/22759470.html Mon, 12 Feb 2024 18:00:00 -0400 4NCA A.30400265 MEDV MEDVD MEDVF O.05948651 O.49066140 http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Telehealth+Platform+Development+Contract+and+Change+of+Officers+and+Directors/22630733.html <p align="justify">TORONTO, Jan. 15, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“<strong>Medivolve</strong>” or the “<strong>Company</strong>”) (NEO: MEDV; OTC: MEDVF; FRA:4NC) is pleased to announce that it has entered into a master services agreement dated December 29, 2023, with Engineer.ai Corp. (dba Builder.ai) (“<strong>Builder</strong>”) to assist in the development of its telehealth platform. Pursuant to the agreement, Builder will develop robust features of the platform, including but not limited to, provider and patient interfacing, telehealth video conferencing, appointment scheduling and management tools, credit card payment processing and more. Features of the platform aim to additionally integrate through Company API interfaces http://www.streetinsider.com/Press+Releases/Medivolve+Announces+Telehealth+Platform+Development+Contract+and+Change+of+Officers+and+Directors/22630733.html Mon, 15 Jan 2024 21:00:00 -0400 4NCA MEDV MEDVD MEDVF O.05948651